Section 3(d) of India’s patent law may be putting India at a competitive disadvantage. The data presented in this research note shows it is preventing Indian generic pharmaceutical companies from developing new formulations, compositions, and combinations of existing medicines, which they instead undertake and commercialise abroad.
Según un estudio de Libertad y Progreso y Geneva Network, la Argentina es el país con el peor marco de protección al derecho de propiedad intelectual entre los países del G20, Este es un claro obstáculo para la llegada de inversiones y el desarrollo de la industria del conocimiento.
For middle-income countries looking to diversify their economies and graduate to high-income status, IPRs are more important today than at any other point in history. Using compulsory licenses to achieve public health objectives is short-termist, anachronistic and counterproductive in the long run.
Much of the public discourse about free trade focuses on the supposed dangers it poses to the environment, to vulnerable communities around the world and to our health. Geneva Network has teamed up with the IFT to produce a pamphlet explaining the role of open trade in improving public health.
As South Africa looks to the future, it can learn from its BRICS partners. China’s focus on innovation, while simultaneously addressing access to medicines, means it is far more in tune with the twenty first century.
The OECD risks weakening its brand by permitting accession of a country that does not fully respect basic market institutions such as intellectual property rights, writes Philip Stevens.
Delinkage is not a silver bullet and can be politicised this is what is being discussed at the joint World Health Organization and Government of India meeting in New Delhi which is part of an international push led by countries, including India, and backed by NGOs, to slash drug prices.
without a more hospitable environment for innovative companies South Africa will stay marooned in its middle-income status. Legislators should therefore view the draft IP bill as an opportunity to turn the ship around.
This WIPO Global Challenges Report describes the innovation process for vaccines. It explains how the restricted availability of vaccines is due to impediments at every stage of the process. Most of these obstacles are manageable, and intellectual property rights are associated with only some of them.